Symphony International Holdings Limited is a private equity and venture capital firm specializing in investments in early stage, management buy-outs, management buy-ins, restructurings, special situations, and the provision of growth capital for later-stage development and expansion. It also invests in real estate development. The firm typically invests in innovative and high-growth consumer businesses primarily in the healthcare, healthcare related services, luxury branded real estate, hospitality and lifestyle sectors. It prefers to make long-term direct investments in the Asia Pacific region with a focus on Australia, India, Indonesia, Malaysia, Singapore, Taiwan, Thailand, Vietnam and Sri Lanka. The firm seeks to achieve control positions in partnership with the management of the acquired business. It seeks to be the lead or sole investor. Symphony International Holdings Limited was founded in 2004 and is based in British Virgin Islands.
19 September 2019 Investment in ASG Hospital Private Limited Symphony International Holdings Limited (LSE: SIHL) is pleased to announce that it has, through a wholly-owned subsidiary, entered into a transaction for an investment in ASG Hospital Private Limited ("ASG"), a full service eye-healthcare provider with operations in India, Africa and Nepal. ASG was co-founded in Rajasthan, India in 2005 by Dr. Arun Singhvi and Dr. Shashank Gang. ASG's operations have since grown to 33 clinics, which offer a full range of eye-healthcare services, including outpatient consultation and a full suite of inpatient procedures (cataract, retina surgeries, Lasik, glaucoma, cornea and other complicated eye surgeries). ASG also operates an optical and pharmacy business, which is located within clinics. Symphony is investing alongside Foundation Holdings, a global investment firm focused on building sustainable, industry defining companies in India and GCC's healthcare and education sectors. Symphony and Foundation are, in equal proportion, investing in ASG. Symphony will have a significant minority interest in ASG at a cost of less than 5% of NAV. Anil Thadani, Chairman of Symphony Asia Holdings Pte. Ltd. and a Director of Symphony, said: "We are excited with the opportunity to partner with Dr. Arun Singhvi and Dr. Shashank Gang to further build the ASG business. The Symphony management team have extensive experience investing in and building healthcare businesses and we look forward to adding value with Foundation Holdings to the ASG business" http://otp.investis.com/clients/uk/symphony_asia1/rns/regulatory-story.aspx?cid=392&newsid=1330123
